1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Nanobiotechnology Market
2.2. Global Nanobiotechnology Market, By Technology Type, 2023 (US$ Million)
2.3. Global Nanobiotechnology Market, By Applications, 2023 (US$ Million)
2.4. Global Nanobiotechnology Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Nanobiotechnology Market: Competitive Analysis
3.1. Market Positioning of Key Nanobiotechnology Market Vendors
3.2. Strategies Adopted by Nanobiotechnology Market Vendors
3.3. Key Industry Strategies
4. Nanobiotechnology Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Nanobiotechnology Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Bio-nanomaterials
5.3.2. Nanoparticles
5.3.3. Nanocrystals
5.3.4. Quantum dots
5.3.5. Liposomes
5.3.6. Polymer Structures Dendrimers
5.3.7. Nanopores
5.3.8. Integrated Nanostructures

6. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Drug Delivery
6.3.2. Sequencing
6.3.3. Biologic Imaging
6.3.4. Research Tools
6.3.5. Microbicide


7. North America Nanobiotechnology Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
7.3. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
7.4.Nanobiotechnology Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
7.4.1.1.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
7.4.1.2.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
7.4.1.3.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)

8. UK and European Union Nanobiotechnology Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.3. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
8.4.Nanobiotechnology Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.1.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.2.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.3.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.4.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.5.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.6.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)

9. Asia Pacific Nanobiotechnology Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.3. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
9.4.Nanobiotechnology Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.1.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.2.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.3.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.4.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.5.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.6.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)

10. Latin America Nanobiotechnology Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
10.3. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
10.4.Nanobiotechnology Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
10.4.1.1.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
10.4.1.2.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
10.4.1.3.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)

11. Middle East and Africa Nanobiotechnology Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
11.3. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
11.4.Nanobiotechnology Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
11.4.1.1.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
11.4.1.2.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Nanobiotechnology Market: By Technology Type, 2022-2032, USD (Million)
11.4.1.3.2. Nanobiotechnology Market: By Applications, 2022-2032, USD (Million)

12. Company Profile
12.1. Aduro BioTech
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Calando Pharmaceuticals Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Baxter International, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Fresinuns Kabi AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Smith & Nephew plc
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Biosante Phosphate Pharmaceuticals Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Celgene Corporation
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Elan Pharmaceuticals Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Flamel Technologies Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Nanophase Technologies Corporation
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Sigma Aldrich Company
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Dendritic Nanotechnologies Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. SkyePharma Pharmaceuticals
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives